EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Global Biopharma to convene in Berlin for BIO-Europe® 2017

Carlsbad, CA and Berlin, Germany – August 28, 2017: The 23rd annual BIO-Europe® 2017 global life science partnering event will be held in Berlin, November 6–8, 2017, in partnership with Berlin Partner and Berlin-Brandenburg HealthCapital. The event is expected to bring together over 3,900 executives from 2,000+ life science companies spanning an estimated 60+ countries to engage in one-to-one partnering.

Berlin is a vital biopharma and health sector with many new digital health startups. Almost 600 life science businesses are based in Berlin, including more than 240 biotech, 300 medical technology and 30 pharmaceutical companies like Bayer, Pfizer and Sanofi.

“Berlin is not only a popular tourist city but is a leading location for biopharmaceutical innovation,”  said  Dr. Kai Uwe Bindseil, Cluster Manager for Healthcare Industries in Berlin-Brandenburg – HealthCapital. “It’s a central hub for governmental and political decisionmakers and Federal Government institutions, as well as patient groups and associations, which together form a cohesive community to shape the business and future of human health.”

“We are pleased to partner with Berlin Partner to bring BIO-Europe to Berlin,” said Anna Chrisman, Group Managing Director, EBD Group. “Berlin-Brandenburg is one of the leading life sciences and healthcare industries centers in the world, and is the perfect setting for the dealmaking and discovery that takes place at BIO-Europe to further global drug development.”

BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. The event is a draw for executives in the life sciences who will gain direct access to service and manufacturing partners, innovative assets, and ideas from biotech companies ranging from very early stage to large, established companies. The event is also a critical business strategy for biotech companies to meet with pharma executives and investors to propel their drug development commercialization goals.

BIO-Europe 2016 broke records for number of delegates and number of one-to-one partnering meetings which reached 20,833, an all-time high and up 9% from 2015. CEOs and decision makers from 1,982 companies and 63 countries discussed asset deals and strategic collaborations. There were 4,734 licensing opportunities on offer, 153 company presentations and 97 exhibitors.


Register for BIO-Europe 2017 before August 31, 2017 and save EUR 200 off the regular registration rate.

Read more on Berlin’s supercluster here. For news and interviews with executives and thought leaders in the life science industry, go to EBD Group’s Partnering Insight.

# # #

Additional links and information:

Follow BIO-Europe 2017 on Twitter:  @EBDGroup (hashtag: #BIOEUROPE).

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Innovation Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton
  • Digital Medicine & Medtech Showcase, at the intersection of technology and medicine
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
  • Cell & Gene Exchange, a partnering forum focused on the patient community in cell and gene therapy sectors, co-produced with Alliance for Regenerative Medicine (ARM).


EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world. Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life science industry.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.


Erin Righetti
EBD Group
+1 760 930 0500